Qualitest is an American pharmaceutical company that produces generic drugs. Qualitest has manufacturing facilities in Charlotte, North Carolina, and Huntsville, AL.[1]

In 2010, Qualitest joined Endo International plc – a global specialty healthcare company focused on improving patients’ lives while creating shareholder value. Endo develops, manufactures, markets, and distributes quality branded pharmaceutical, generic and device products through its operating companies. Endo has global headquarters in Dublin, Ireland and US headquarters in Malvern, PA.[1]

DAVA Pharmaceuticals, Inc. is now part of Qualitest Pharmaceuticals, an Endo International plc company.[1]

Boca Pharmacal is a specialty generics company with a unique generics product portfolio and complementary pipeline that builds on Qualitest’s strength in controlled substances.


In May, 2015 Endo International plc (NASDAQ: ENDP) (TSX: ENL) and Par Pharmaceutical Holdings, Inc. announced that they have entered into a definitive agreement under which Endo will acquire privately held Par from TPG in a transaction valued at $8.05 billion, including assumption of Par debt.[1]


In 2015, over one hundred women have filed legal action against the company.[3]

See also


  1. 1 2 3 4 "Qualitest® - An Endo International Company". Qualitestrx.com. Retrieved 2015-11-13.
  2. Archived November 17, 2015, at the Wayback Machine.
  3. "Over 100 Women Sue After Birth Control Blunder Leaves Them Pregnant". Msn.com. Retrieved 2015-11-13.
This article is issued from Wikipedia - version of the 11/14/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.